Results 101 to 110 of about 14,564 (189)
LifePurpose: To describe the indication spectrum for high-dose 8 mg aflibercept for neovascular age-related macular degeneration (nAMD) in a real-world cohort in a tertiary referral center.
Caspar Liesenhoff +10 more
doaj +1 more source
, 2023 Fernando Munayco-Guillén,1,2 Miguel Angel Vazquez-Membrillo,1,2 Marlon Rafael Garcia-Roa,1,2 Jhony Alberto De La Cruz-Vargas,3 Herney Andrés García-Perdomo,4 Rafael Pichardo-Rodriguez3 1Department of Retina and Vitreous Surgery, Instituto Mexicano de ...
Munayco-Guillén F +5 more
core
PharmaceuticalsPurpose: The aim was to compare the short-term outcomes of aflibercept 8 mg and brolucizumab for the treatment of polypoidal choroidal vasculopathy (PCV). Methods: This study included 48 eyes of 48 patients with PCV.
Yoshiko Fukuda +4 more
doaj +1 more source
Evaluation of pain during intravitreal aflibercept injections
, 2017 Purpose: To evaluate the pain associated with intravitreal aflibercept injections. Methods: The study included 119 patients who received intravitreal aflibercept injection at a single institution.
Mustafa A. Anayol +4 more
core +1 more source
The efficacy and safety of aflibercept and conbercept in diabetic macular edema
, 2018 Siwei Cai, Qianhui Yang, Xiaorong Li, Yan Zhang Tianjin Medical University Eye Hospital, Tianjin Medical University Eye Institute, College of Optometry and Ophthalmology, Tianjin Medical University, Tianjin 300384, People’s Republic of China ...
Li X, Cai S, Zhang Y, Yang Q
core
Debdulal Chakraborty,1 Subhendu Boral,1 Tushar Kanti Sinha,1 Arnab Das,1 Angshuman Mukherjee,1 Saptorshi Majumdar,1 Ranabir Bhattacharya,2 Ritobroto Maitra3 1Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, West Bengal, India ...
Majumdar S +7 more
core
3D modeling of aflibercept transport in the vitreous humor [PDF]
, 2017 Aflibercept is an anti-vascular endothelial growth factor (anti-VEGF) drug used to treat several retinal diseases such as macular degeneration. It accomplishes this by binding and inhibiting VEGF, which is the growth factor that is responsible for ...
Limjoco, Matthew +2 more
core
Purpose: To compare early intraocular pressure (IOP) dynamics following intravitreal injections of aflibercept 8 mg versus aflibercept 2 mg using propensity score-matched analysis with fellow eye controls.
Martin A. A. +4 more
core +1 more source
Eye Drop Development of Anti-VEGF Therapeutics by Ocular Penetrating Carrier to the Posterior Region of the Eye. [PDF]
Transl Vis Sci TechnolChiueh VC +5 more
europepmc +1 more source
Clinical OphthalmologyHazem Saleh Aljuhani,1,* Rahaf A Hubayni,2,3,* Jumanah Qedair,2,3 Ziad M Bukhari,4 Ahmed Alzahrani,4 Razan Osama Bawazir,2,3 Orjwan Salah Badghaish,2,3 Faisal Alqahtani5 1Ophthalmology Department, Jeddah Eye Hospital, Jeddah, Saudi Arabia;
Aljuhani HS +7 more
doaj